A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer
Clinical trial NCT01491737 · COMPLETED
Trial details
- NCT number
- NCT01491737
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-17
- Primary completion
- 2016-03-17
- Enrollment
- 258
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.